Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain-Reference-Cited by-同舟云学术

Number of drugs used in secondary cardiovascular prevention and late survival in the population of Valencia Community, Spain

Published:2019-10 Issue: Volume:293 Page:260-265
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Redón Josep,Usó Ruth,Trillo Jose Luis,López Cristina,Morales-Olivas Francisco,Navarro Jorge,Sanchís Juan,Gil Vicente,Orozco-Beltrán Domingo

Funder

Ferrer

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference33 articles.

1. The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction;Bramlage;Heart,2010

2. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain;Sanfélix-Gimeno;J. Manag. Care Pharm.,2013

3. Randomized clinical trial to assess the efficacy of a comprehensive programme of secondary prevention of cardiovascular disease in general practice: the PREseAP study;Brotons;Rev. Esp. Cardiol.,2011

4. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

5. Acute myocardial infarction;Anderson;N. Engl. J. Med.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Analysis of Lipid-Lowering and Antiplatelet Therapy Regimen by Clinical Decision Support Service Based on Real-World Data from Electronic Medical Records “Intellect 3 Study”;Kardiologiia;2023-12-05

2. Metabolic Blood Hormones in Young People With Electrocardiographic Signs of Ischemic Myocardial Changes;Kardiologiia;2023-12-05

3. Economic Burden Associated with the Treatment with a Cardiovascular Polypill in Secondary Prevention in Spain: Cost-Effectiveness Results of the NEPTUNO Study;ClinicoEconomics and Outcomes Research;2023-07

4. Real world evidence: Perspectives from a European Society of Cardiology Cardiovascular Round Table with contribution from the European Medicines Agency;European Heart Journal - Quality of Care and Clinical Outcomes;2023-02-06

5. Nurse-led and Interdisciplinary Secondary Cardiovascular Prevention Programmes: Spanish Cohort of the EUROACTION Project;Endocrine, Metabolic & Immune Disorders - Drug Targets;2022-11